{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:24:20Z","timestamp":1787271860424,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025092","name":"Ministry of Health, Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010289","name":"Princess Margaret Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025090","name":"Ministry of Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.030","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:30:12Z","timestamp":1787182212000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer risk among survivors of hematopoietic stem cell transplant with or without total body irradiation: A population-based analysis"],"prefix":"10.1016","author":[{"given":"Helena J. Janse","family":"van Rensburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7733-9109","authenticated-orcid":false,"given":"Jingxuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0367-2219","authenticated-orcid":false,"given":"Jean M.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Paszat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-7168","authenticated-orcid":false,"given":"Jeffrey H.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2026.08.030_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7861\/clinmedicine.17-2-137","article-title":"The late medical effects of cancer treatments: a growing challenge for all medical professionals","volume":"17","author":"Harrington","year":"2017","journal-title":"Clin Med (Lond)"},{"issue":"14","key":"10.1016\/j.jtct.2026.08.030_bib0002","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.030_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.semradonc.2009.09.002","article-title":"Secondary malignancies across the age spectrum","volume":"20","author":"Ng","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jtct.2026.08.030_bib0004","unstructured":"National Comprehensive Cancer Network. Hematopoietic Cell Transplantation Guidelines."},{"issue":"4","key":"10.1016\/j.jtct.2026.08.030_bib0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.030_bib0006","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-141-8-200410190-00006","article-title":"Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"141","author":"Kenney","year":"2004","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.030_bib0007","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ijc.22261","article-title":"Risk of breast cancer in female survivors of childhood Hodgkin\u2019s disease in Britain: a population-based study","volume":"120","author":"Taylor","year":"2007","journal-title":"Int J Cancer"},{"issue":"21","key":"10.1016\/j.jtct.2026.08.030_bib0008","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.08.030_bib0009","unstructured":"Cancer Care Ontario. Breast Cancer Screening Guidelines. Cancer Care Ontario."},{"issue":"6","key":"10.1016\/j.jtct.2026.08.030_bib0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2017.02.015","article-title":"Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience","volume":"23","author":"Michelis","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.030_bib0011","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jtct.2023.12.001","article-title":"International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update","volume":"30","author":"Rotz","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.030_bib0012","unstructured":"Cancer Care Ontario. Screening for secondary solid malignancies after stem cell transplantation. Cancer Care Ontario."},{"issue":"25","key":"10.1016\/j.jtct.2026.08.030_bib0013","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.20.00231","article-title":"Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report","volume":"38","author":"McDonald","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.08.030_bib0014","unstructured":"ICES Data Dictionary. Available at: https:\/\/datadictionary.ices.on.ca\/Applications\/DataDictionary\/Default.aspx"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.030_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039293","article-title":"Utilisation and outcomes of allogeneic hematopoietic cell transplantation in Ontario, Canada, and New York State, USA: a population-based retrospective cohort study","volume":"10","author":"Hershenfeld","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.030_bib0016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41408-025-01416-4","article-title":"Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study","volume":"15","author":"Salter","year":"2025","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.030_bib0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-008-9986-4","article-title":"Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series","volume":"114","author":"Paszat","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"446","key":"10.1016\/j.jtct.2026.08.030_bib0018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.jtct.2026.08.030_bib0019","unstructured":"SAS Institute Inc., Cary, NC, USA."},{"issue":"2","key":"10.1016\/j.jtct.2026.08.030_bib0020","first-page":"205","article-title":"Secondary Neoplasm in Survivors of Childhood Hematological Malignancies-Systematic Review","volume":"13","author":"Horne\u021b","year":"2026","journal-title":"Children (Basel)"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.030_bib0021","first-page":"477","article-title":"Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation","volume":"27","author":"Latz","year":"2004","journal-title":"Onkologie"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.030_bib0022","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000121395","article-title":"Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia","volume":"31","author":"Lowe","year":"2008","journal-title":"Onkologie"},{"issue":"26","key":"10.1016\/j.jtct.2026.08.030_bib0023","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.030_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08880018.2019.1591549","article-title":"The impact of severe late-effects after 12\u2009Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010)","volume":"36","author":"Freycon","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.030_bib0025","article-title":"Adverse Effects of Total Body Irradiation: A Two-Decade, Single Institution Analysis","volume":"6","author":"Pearlman","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.030_bib0026","article-title":"Long-Term Toxicity after Non-Myeloablative Conditioning Regimens Using Total Body Irradiation","volume":"10","author":"Patel","year":"2025","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.030_bib0027","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/bmt.2015.4","article-title":"Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT","volume":"50","author":"Pole","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.030_bib0028","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.030_bib0029","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jtct.2026.04.025","article-title":"Secondary Malignancies After Hematopoietic Stem Cell Transplantation","volume":"32","author":"Asensi Cant\u00f3","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.030_bib0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood-2007-07-099283","article-title":"Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party","volume":"111","author":"Friedman","year":"2008","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jtct.2026.08.030_bib0031","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","article-title":"High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease: report from the Late Effects Study Group","volume":"21","author":"Bhatia","year":"2003","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.jtct.2026.08.030_bib0032","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","article-title":"Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin\u2019s lymphoma in England and Wales: a National Cohort Study","volume":"30","author":"Swerdlow","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.030_bib0033","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.030_bib0034","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.jtct.2026.08.030_bib0035","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.030_bib0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","article-title":"Breast Cancer After Treatment of Hodgkin\u2019s Disease","volume":"85","author":"Hancock","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.030_bib0037","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1634\/theoncologist.2011-0451","article-title":"Risk, Characteristics, and Prognosis of Breast Cancer after Hodgkin\u2019s Lymphoma","volume":"17","author":"Veit-Rubin","year":"2012","journal-title":"The Oncologist"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.030_bib0038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-12-197","article-title":"Risk of second breast cancer in female Hodgkin\u2019s lymphoma survivors: a meta-analysis","volume":"12","author":"Ibrahim","year":"2012","journal-title":"BMC Cancer"},{"issue":"24","key":"10.1016\/j.jtct.2026.08.030_bib0039","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study","volume":"27","author":"Inskip","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.030_bib0040","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jamapediatrics.2019.3807","article-title":"Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study","volume":"173","author":"Veiga","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.030_bib0041","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijrobp.2024.12.016","article-title":"Radiation Doses to the Breast and Predicted Breast Cancer Risk Among Patients Treated for Hodgkin Lymphoma With Modern Radiation Therapy","volume":"122","author":"Roberti","year":"2025","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.030_bib0042","first-page":"453","article-title":"Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate","volume":"8","author":"Fyles","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.030_bib0043","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.bbmt.2012.07.017","article-title":"Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbidities","volume":"18","author":"Daly","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.030_bib0044","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ccr.2011.03.011","article-title":"Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type","volume":"19","author":"Nguyen","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.030_bib0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaoncol.2018.4934","article-title":"Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients","volume":"5","author":"Tichelli","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600672X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600672X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:41:44Z","timestamp":1787269304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600672X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S266663672600672X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.030","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer risk among survivors of hematopoietic stem cell transplant with or without total body irradiation: A population-based analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}